Vaxart, Inc. SEC Filings https://investors.aviragentherapeutics.com/ Vaxart, Inc. SEC Filings en 4: Statement of changes in beneficial ownership of securities https://investors.aviragentherapeutics.com/sec-filings/sec-filing/4/0001437749-19-012107 NABI BIOPHARMACEUTICALS Fri, 14 Jun 2019 17:04:37 -0400 Vaxart, Inc. SEC Filings 14841 4: Statement of changes in beneficial ownership of securities https://investors.aviragentherapeutics.com/sec-filings/sec-filing/4/0001437749-19-012100 NABI BIOPHARMACEUTICALS Fri, 14 Jun 2019 16:36:40 -0400 Vaxart, Inc. SEC Filings 14836 4: Statement of changes in beneficial ownership of securities https://investors.aviragentherapeutics.com/sec-filings/sec-filing/4/0001437749-19-012099 NABI BIOPHARMACEUTICALS Fri, 14 Jun 2019 16:36:38 -0400 Vaxart, Inc. SEC Filings 14826 4: Statement of changes in beneficial ownership of securities https://investors.aviragentherapeutics.com/sec-filings/sec-filing/4/0001437749-19-012102 NABI BIOPHARMACEUTICALS Fri, 14 Jun 2019 16:36:38 -0400 Vaxart, Inc. SEC Filings 14831 4: Statement of changes in beneficial ownership of securities https://investors.aviragentherapeutics.com/sec-filings/sec-filing/4/0001437749-19-012101 NABI BIOPHARMACEUTICALS Fri, 14 Jun 2019 16:36:37 -0400 Vaxart, Inc. SEC Filings 14821 8-K: Report of unscheduled material events or corporate event https://investors.aviragentherapeutics.com/sec-filings/sec-filing/8-k/0001437749-19-010827 NABI BIOPHARMACEUTICALS Fri, 24 May 2019 16:07:03 -0400 Vaxart, Inc. SEC Filings 14811 8-K: Report of unscheduled material events or corporate event https://investors.aviragentherapeutics.com/sec-filings/sec-filing/8-k/0001437749-19-010237 NABI BIOPHARMACEUTICALS Thu, 16 May 2019 16:04:57 -0400 Vaxart, Inc. SEC Filings 14806 4: Statement of changes in beneficial ownership of securities https://investors.aviragentherapeutics.com/sec-filings/sec-filing/4/0001209191-19-029721 NABI BIOPHARMACEUTICALS Tue, 14 May 2019 17:30:18 -0400 Vaxart, Inc. SEC Filings 14801 4: Statement of changes in beneficial ownership of securities https://investors.aviragentherapeutics.com/sec-filings/sec-filing/4/0001209191-19-029720 NABI BIOPHARMACEUTICALS Tue, 14 May 2019 17:28:18 -0400 Vaxart, Inc. SEC Filings 14796 4: Statement of changes in beneficial ownership of securities https://investors.aviragentherapeutics.com/sec-filings/sec-filing/4/0001209191-19-029716 NABI BIOPHARMACEUTICALS Tue, 14 May 2019 17:20:22 -0400 Vaxart, Inc. SEC Filings 14791